Doctor profile · Federal record
Dr. HISHAM EL-KADI, MD
Rheumatology Physician (CMS: RHEUMATOLOGY) · FREEHOLD, NJ
- NPI 1184698466
- Accepts Medicare
- MIPS 94.1 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4247 ROUTE 9 N, BUILDING 1
FREEHOLD, NJ 077288307
(732) 780-7650
fax (732) 780-8817
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- May 28, 2014
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #MA056265
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184698466. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
250,826
Distinct HCPCS
10
Medicare allowed
$3,785,363
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 89,281 | 26 | $5 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 52,800 | 29 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 24,200 | 44 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 23,702 | 271 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 20,602 | 27 | $13 | |
J0131 |
Injection, acetaminophen, not otherwise specified,10 mg | 15,205 | 73 | $0 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 10,480 | 39 | $33 | |
J7318 |
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 3,367 | 28 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 2,632 | 857 | $138 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 1,344 | 320 | $8 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 4,184. This provider delivers 60× the peer median.Open Payments
Industry payments received
All-time total
$856
Transactions
45
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 24 | $425.92 | |
| Novartis Pharmaceuticals Corporation | 5 | $103.00 | |
| Zimmer Biomet Holdings, Inc. | 1 | $71.44 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $63.13 | |
| Amgen Inc. | 4 | $61.93 | |
| UCB, Inc. | 2 | $33.52 | |
| Bioventus LLC | 1 | $25.07 | |
| BIOTRONIK NRO, Inc. | 1 | $21.49 | |
| GENZYME CORPORATION | 1 | $21.11 | |
| Janssen Biotech, Inc. | 1 | $15.15 | |
| GlaxoSmithKline, LLC. | 1 | $14.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,193
Patients
431
Total drug cost
$517,083
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tramadol Hcl | Generic | 192 | 53 | $1,590 |
| Prednisone | Generic | 185 | 96 | $3,824 |
| Hydroxychloroquine Sulfate | Generic | 167 | 60 | $13,052 |
| Methotrexate (Methotrexate Sodium) | Brand | 114 | 44 | $3,940 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 74 | 23 | $1,884 |
| Meloxicam | Generic | 69 | 25 | $554 |
| Allopurinol | Generic | 63 | 19 | $898 |
| Enbrel Sureclick (Etanercept) | Brand | 56 | 0 | $475,607 |
| Gabapentin | Generic | 46 | 16 | $772 |
| Alprazolam | Generic | 43 | 16 | $752 |